nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—atherosclerosis	0.673	1	CbGaD
Acepromazine—ALB—Rosuvastatin—atherosclerosis	0.0087	1	CbGbCtD
Acepromazine—HTR2A—arteriole—atherosclerosis	0.00652	0.248	CbGeAlD
Acepromazine—HTR2A—vein—atherosclerosis	0.00389	0.148	CbGeAlD
Acepromazine—HTR2A—hindlimb—atherosclerosis	0.00258	0.0983	CbGeAlD
Acepromazine—HTR2A—appendage—atherosclerosis	0.00222	0.0843	CbGeAlD
Acepromazine—Isothipendyl—HRH1—atherosclerosis	0.00206	0.11	CrCbGaD
Acepromazine—Aceprometazine—HRH1—atherosclerosis	0.00178	0.0956	CrCbGaD
Acepromazine—Methdilazine—HRH1—atherosclerosis	0.00165	0.0885	CrCbGaD
Acepromazine—HTR2A—artery—atherosclerosis	0.00158	0.0603	CbGeAlD
Acepromazine—HTR2A—endothelium—atherosclerosis	0.00134	0.0509	CbGeAlD
Acepromazine—Olopatadine—HRH1—atherosclerosis	0.00132	0.0708	CrCbGaD
Acepromazine—HTR2A—blood vessel—atherosclerosis	0.00123	0.0469	CbGeAlD
Acepromazine—Alimemazine—HRH1—atherosclerosis	0.0012	0.0646	CrCbGaD
Acepromazine—Mequitazine—HRH1—atherosclerosis	0.00103	0.0556	CrCbGaD
Acepromazine—SLC22A1—adipose tissue—atherosclerosis	0.000986	0.0375	CbGeAlD
Acepromazine—HTR1A—cardiovascular system—atherosclerosis	0.000923	0.0351	CbGeAlD
Acepromazine—ADRA1A—cardiovascular system—atherosclerosis	0.000851	0.0324	CbGeAlD
Acepromazine—ADRA1A—adipose tissue—atherosclerosis	0.000751	0.0286	CbGeAlD
Acepromazine—Thiothixene—HRH1—atherosclerosis	0.000736	0.0395	CrCbGaD
Acepromazine—Mesoridazine—HRH1—atherosclerosis	0.000726	0.039	CrCbGaD
Acepromazine—Prochlorperazine—HRH1—atherosclerosis	0.000703	0.0378	CrCbGaD
Acepromazine—SLC22A1—liver—atherosclerosis	0.000691	0.0263	CbGeAlD
Acepromazine—ALB—liver—atherosclerosis	0.000662	0.0252	CbGeAlD
Acepromazine—Fluphenazine—HRH1—atherosclerosis	0.000636	0.0342	CrCbGaD
Acepromazine—HTR2A—connective tissue—atherosclerosis	0.000632	0.0241	CbGeAlD
Acepromazine—Propiomazine—HRH1—atherosclerosis	0.000612	0.0329	CrCbGaD
Acepromazine—Chlorprothixene—HRH1—atherosclerosis	0.000579	0.0311	CrCbGaD
Acepromazine—HTR2A—cardiovascular system—atherosclerosis	0.00055	0.0209	CbGeAlD
Acepromazine—Thioridazine—HRH1—atherosclerosis	0.000548	0.0294	CrCbGaD
Acepromazine—Trimipramine—HRH1—atherosclerosis	0.000535	0.0288	CrCbGaD
Acepromazine—ADRA1A—liver—atherosclerosis	0.000526	0.02	CbGeAlD
Acepromazine—Methotrimeprazine—HRH1—atherosclerosis	0.000523	0.0281	CrCbGaD
Acepromazine—Promethazine—HRH1—atherosclerosis	0.000515	0.0277	CrCbGaD
Acepromazine—Trifluoperazine—HRH1—atherosclerosis	0.000508	0.0273	CrCbGaD
Acepromazine—Perphenazine—HRH1—atherosclerosis	0.000503	0.027	CrCbGaD
Acepromazine—Desipramine—HRH1—atherosclerosis	0.000468	0.0251	CrCbGaD
Acepromazine—Promazine—HRH1—atherosclerosis	0.000453	0.0244	CrCbGaD
Acepromazine—Chlorpromazine—HRH1—atherosclerosis	0.000399	0.0214	CrCbGaD
Acepromazine—Imipramine—HRH1—atherosclerosis	0.000397	0.0213	CrCbGaD
Acepromazine—HTR2A—liver—atherosclerosis	0.00034	0.013	CbGeAlD
Acepromazine—Thioproperazine—ALB—atherosclerosis	0.000173	0.00928	CrCbGaD
Acepromazine—Thiothixene—ALB—atherosclerosis	0.00017	0.00913	CrCbGaD
Acepromazine—Pipotiazine—ALB—atherosclerosis	0.00017	0.00913	CrCbGaD
Acepromazine—Clomipramine—ALB—atherosclerosis	0.000134	0.00722	CrCbGaD
Acepromazine—Chlorpromazine—ALB—atherosclerosis	9.21e-05	0.00495	CrCbGaD
Acepromazine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	3.19e-05	0.000117	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LPL—atherosclerosis	3.18e-05	0.000116	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MTHFR—atherosclerosis	3.18e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOB—atherosclerosis	3.17e-05	0.000116	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AGT—atherosclerosis	3.16e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	3.15e-05	0.000115	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SOCS3—atherosclerosis	3.13e-05	0.000115	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	3.12e-05	0.000114	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PPARA—atherosclerosis	3.12e-05	0.000114	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—LEP—atherosclerosis	3.1e-05	0.000113	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—APOE—atherosclerosis	3.1e-05	0.000113	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	3.1e-05	0.000113	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	3.09e-05	0.000113	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	3.08e-05	0.000113	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CAV1—atherosclerosis	3.07e-05	0.000112	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—APOA1—atherosclerosis	3.07e-05	0.000112	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.04e-05	0.000111	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LPL—atherosclerosis	3.03e-05	0.000111	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP3—atherosclerosis	3.03e-05	0.000111	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	3.02e-05	0.00011	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AGT—atherosclerosis	3.02e-05	0.00011	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF2—atherosclerosis	3.01e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SPP1—atherosclerosis	3.01e-05	0.00011	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ABCA1—atherosclerosis	3.01e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	3e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP3—atherosclerosis	2.98e-05	0.000109	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF2—atherosclerosis	2.96e-05	0.000108	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ESR1—atherosclerosis	2.96e-05	0.000108	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APOE—atherosclerosis	2.96e-05	0.000108	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	2.95e-05	0.000108	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CAV1—atherosclerosis	2.93e-05	0.000107	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOB—atherosclerosis	2.92e-05	0.000107	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—F2—atherosclerosis	2.92e-05	0.000107	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APOA1—atherosclerosis	2.92e-05	0.000107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	2.92e-05	0.000107	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	2.9e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	2.9e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EDN1—atherosclerosis	2.88e-05	0.000105	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOB—atherosclerosis	2.88e-05	0.000105	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	2.87e-05	0.000105	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	2.86e-05	0.000104	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL5—atherosclerosis	2.86e-05	0.000104	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	2.85e-05	0.000104	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EDN1—atherosclerosis	2.83e-05	0.000104	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	2.82e-05	0.000103	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL5—atherosclerosis	2.81e-05	0.000103	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	2.8e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	2.79e-05	0.000102	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LPL—atherosclerosis	2.79e-05	0.000102	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	2.79e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	2.77e-05	0.000101	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	2.75e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LPL—atherosclerosis	2.75e-05	0.0001	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AGT—atherosclerosis	2.72e-05	9.95e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	2.72e-05	9.93e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	2.69e-05	9.84e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	2.68e-05	9.8e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	2.67e-05	9.77e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	2.67e-05	9.76e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LEP—atherosclerosis	2.67e-05	9.75e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APOE—atherosclerosis	2.67e-05	9.75e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	2.65e-05	9.71e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—INS—atherosclerosis	2.65e-05	9.68e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SPP1—atherosclerosis	2.65e-05	9.67e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CAV1—atherosclerosis	2.64e-05	9.66e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APOA1—atherosclerosis	2.64e-05	9.64e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	2.63e-05	9.63e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—VEGFA—atherosclerosis	2.63e-05	9.63e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	2.62e-05	9.56e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL2—atherosclerosis	2.61e-05	9.53e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SPP1—atherosclerosis	2.6e-05	9.52e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AGT—atherosclerosis	2.59e-05	9.47e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	2.59e-05	9.47e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HMOX1—atherosclerosis	2.58e-05	9.43e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PPARG—atherosclerosis	2.58e-05	9.42e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF1—atherosclerosis	2.56e-05	9.37e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	2.55e-05	9.32e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ESR1—atherosclerosis	2.55e-05	9.31e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LEP—atherosclerosis	2.54e-05	9.28e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOE—atherosclerosis	2.54e-05	9.28e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	2.54e-05	9.28e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—INS—atherosclerosis	2.53e-05	9.23e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	2.52e-05	9.2e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—F2—atherosclerosis	2.51e-05	9.19e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	2.51e-05	9.18e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—MAPK3—atherosclerosis	2.49e-05	9.11e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOB—atherosclerosis	2.47e-05	9.03e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	2.45e-05	8.95e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	2.43e-05	8.9e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	2.42e-05	8.86e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TGFB1—atherosclerosis	2.42e-05	8.84e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	2.41e-05	8.8e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	2.41e-05	8.8e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GSTM1—atherosclerosis	2.4e-05	8.79e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—F2—atherosclerosis	2.39e-05	8.75e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AGT—atherosclerosis	2.39e-05	8.73e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—LPL—atherosclerosis	2.36e-05	8.63e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	2.36e-05	8.62e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AGT—atherosclerosis	2.35e-05	8.59e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LEP—atherosclerosis	2.34e-05	8.56e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOE—atherosclerosis	2.34e-05	8.56e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NOS3—atherosclerosis	2.32e-05	8.49e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CAV1—atherosclerosis	2.32e-05	8.48e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ALB—atherosclerosis	2.32e-05	8.47e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOA1—atherosclerosis	2.31e-05	8.46e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	2.3e-05	8.43e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LEP—atherosclerosis	2.3e-05	8.42e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOE—atherosclerosis	2.3e-05	8.42e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GPX1—atherosclerosis	2.3e-05	8.42e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	2.3e-05	8.42e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	2.29e-05	8.38e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CAV1—atherosclerosis	2.28e-05	8.34e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INS—atherosclerosis	2.28e-05	8.33e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOA1—atherosclerosis	2.28e-05	8.32e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.26e-05	8.25e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.26e-05	8.25e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CD36—atherosclerosis	2.24e-05	8.2e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL2—atherosclerosis	2.24e-05	8.19e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ESR1—atherosclerosis	2.23e-05	8.17e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.23e-05	8.17e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.23e-05	8.15e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—NOS3—atherosclerosis	2.22e-05	8.1e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—F2—atherosclerosis	2.21e-05	8.07e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1—atherosclerosis	2.2e-05	8.05e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ESR1—atherosclerosis	2.2e-05	8.04e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	2.19e-05	8.02e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—F2—atherosclerosis	2.17e-05	7.94e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INS—atherosclerosis	2.17e-05	7.93e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.15e-05	7.87e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	2.13e-05	7.8e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—F2—atherosclerosis	2.13e-05	7.78e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MTHFR—atherosclerosis	2.12e-05	7.77e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	2.11e-05	7.72e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	2.1e-05	7.67e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	2.09e-05	7.65e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARA—atherosclerosis	2.08e-05	7.62e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	2.08e-05	7.6e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	2.06e-05	7.53e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	2.04e-05	7.44e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTGS2—atherosclerosis	2.03e-05	7.41e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	2.02e-05	7.4e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AGT—atherosclerosis	2.02e-05	7.38e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INS—atherosclerosis	2e-05	7.31e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NOS3—atherosclerosis	2e-05	7.3e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	1.99e-05	7.28e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	1.99e-05	7.28e-05	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.99e-05	7.28e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOE—atherosclerosis	1.98e-05	7.23e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INS—atherosclerosis	1.97e-05	7.19e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL2—atherosclerosis	1.97e-05	7.19e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CAV1—atherosclerosis	1.96e-05	7.16e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—atherosclerosis	1.96e-05	7.16e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOA1—atherosclerosis	1.96e-05	7.15e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	1.95e-05	7.13e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	1.94e-05	7.08e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1—atherosclerosis	1.93e-05	7.07e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INS—atherosclerosis	1.93e-05	7.04e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	1.9e-05	6.96e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	1.9e-05	6.95e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	1.9e-05	6.93e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	1.86e-05	6.81e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MMP9—atherosclerosis	1.86e-05	6.81e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	1.84e-05	6.74e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	1.84e-05	6.72e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	1.81e-05	6.63e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	1.81e-05	6.61e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	1.81e-05	6.61e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PIK3CG—atherosclerosis	1.78e-05	6.53e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	1.77e-05	6.48e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	1.77e-05	6.47e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	1.75e-05	6.41e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	1.73e-05	6.31e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARG—atherosclerosis	1.72e-05	6.3e-05	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	1.71e-05	6.26e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—INS—atherosclerosis	1.69e-05	6.18e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	1.69e-05	6.18e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	1.69e-05	6.17e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	1.68e-05	6.16e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—AKT1—atherosclerosis	1.68e-05	6.14e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	1.67e-05	6.12e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	1.66e-05	6.06e-05	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	1.63e-05	5.96e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	1.6e-05	5.87e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	1.6e-05	5.86e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	1.59e-05	5.8e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	1.58e-05	5.79e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	1.56e-05	5.7e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	1.56e-05	5.69e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	1.55e-05	5.68e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	1.54e-05	5.62e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	1.53e-05	5.6e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.53e-05	5.58e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.51e-05	5.52e-05	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	5.49e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.5e-05	5.48e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.48e-05	5.43e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NOS3—atherosclerosis	1.48e-05	5.42e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.48e-05	5.41e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.48e-05	5.41e-05	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	1.48e-05	5.41e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	1.46e-05	5.32e-05	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.45e-05	5.29e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.44e-05	5.26e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.43e-05	5.21e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.42e-05	5.21e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.41e-05	5.14e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	5.09e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	1.38e-05	5.06e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.37e-05	5.01e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	1.37e-05	5.01e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.37e-05	5e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	4.99e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.36e-05	4.98e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.36e-05	4.96e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.36e-05	4.96e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS2—atherosclerosis	1.36e-05	4.95e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	1.35e-05	4.92e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	1.34e-05	4.91e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.34e-05	4.9e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.32e-05	4.83e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.32e-05	4.82e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.31e-05	4.81e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.3e-05	4.74e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	4.62e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.26e-05	4.6e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.25e-05	4.57e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.24e-05	4.55e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.23e-05	4.5e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.22e-05	4.45e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.21e-05	4.41e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.2e-05	4.37e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.18e-05	4.3e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.16e-05	4.24e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—atherosclerosis	1.16e-05	4.23e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.15e-05	4.21e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.14e-05	4.17e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.12e-05	4.08e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.07e-05	3.9e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AKT1—atherosclerosis	1.02e-05	3.72e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—atherosclerosis	9.95e-06	3.64e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	9.48e-06	3.47e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	9.18e-06	3.36e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	8.74e-06	3.2e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—atherosclerosis	8.74e-06	3.19e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	8.6e-06	3.14e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	8.42e-06	3.08e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	8.06e-06	2.95e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	7.93e-06	2.9e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	7.77e-06	2.84e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKT1—atherosclerosis	6.81e-06	2.49e-05	CbGpPWpGaD
